COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Teagan Ware

Teagan Ware, MSTeagan Ware, MS
Research Associate III, Pharmacology & Toxicology

Mrs. Ware transferred to the NCL as a Cancer Biologist in July 2020, after previously being with the NCI for 3 years working in the Laboratory Animal Sciences Program. Mrs. Ware’s main role in the NCL involves the coordination and scheduling of in vivo pharmacology and toxicology studies, including data analysis and data disclosure. She works closely with the other members of the NCL, as well as other NCI personnel in various programs, to ensure studies are carried out successfully and according to protocol.

Prior to joining the NCI, she was a Staff Scientist with a CRO as part of their in vivo team conducting pharmaceutical research studies; in this role, she assisted in coordinating and running mass balance, pharmacokinetic/pharmacodynamic and whole-body autoradiography pre-clinical studies. Mrs. Ware received her B.S. in Small Animal Science from Delaware Valley University in 2015, with a minor in Large Animal Sciences. In 2018, she then graduated with her M.S. in Laboratory Animal Sciences from Eastern Virginia Medical School. She also received a certificate in Project Management in 2020.